Applying valency-based immuno-selection to generate broadly cross-reactive antibodies against influenza hemagglutinins.
Daniëla Maria HinkeAne Marie AndersonKirankumar KattaMarlene Fyrstenberg LaursenDemo Yemane TesfayeIna Charlotta WerninghausDavide AngelettiGunnveig GrødelandBjarne BogenRanveig BraathenPublished in: Nature communications (2024)
Conserved epitopes shared between virus subtypes are often subdominant, making it difficult to induce broadly reactive antibodies by immunization. Here, we generate a plasmid DNA mix vaccine that encodes protein heterodimers with sixteen different influenza A virus hemagglutinins (HA) representing all HA subtypes except H1 (group 1) and H7 (group 2). Each single heterodimer expresses two different HA subtypes and is targeted to MHC class II on antigen presenting cells (APC). Female mice immunized with the plasmid mix produce antibodies not only against the 16 HA subtypes, but also against non-included H1 and H7. We demonstrate that individual antibody molecules cross-react between different HAs. Furthermore, the mix vaccine induces T cell responses to conserved HA epitopes. Immunized mice are partially protected against H1 viruses. The results show that application of valency-based immuno-selection to diversified antigens can be used to direct antibody responses towards conserved (subdominant) epitopes on viral antigens.
Keyphrases
- escherichia coli
- transcription factor
- induced apoptosis
- crispr cas
- high fat diet induced
- dendritic cells
- cancer therapy
- type diabetes
- single molecule
- circulating tumor
- cell free
- case report
- insulin resistance
- small molecule
- binding protein
- cell death
- endoplasmic reticulum stress
- wild type
- nucleic acid
- circulating tumor cells